Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 1983 Mar 12;286(6368):832-4.
doi: 10.1136/bmj.286.6368.832.

Factors related to first dose hypotensive effect of captopril: prediction and treatment

Case Reports

Factors related to first dose hypotensive effect of captopril: prediction and treatment

G P Hodsman et al. Br Med J (Clin Res Ed). .

Abstract

The blood pressure response to the first dose of captopril (6.25 mg, 12.5 mg, or 25 mg) was measured in 65 treated, severely hypertensive patients. Mean supine blood pressure was 187/108 mm Hg immediately before captopril was given. Twenty one patients experienced a fall in supine systolic pressure greater than 50 mm Hg, including five whose pressure fell more than 100 mm Hg and two whose pressure fell more than 150 mm Hg. Six patients developed symptoms of acute hypotension, including dizziness, stupor, dysphasia, and hemiparesis. Percentage reductions in blood pressure were greatest in those with secondary hypertension (p less than 0.05), high pretreatment blood pressure (p less than 0.05), and high concentrations of plasma renin and angiotensin II (p less than 0.01). No significant correlation was found between fall in blood pressure and serum sodium concentration, age, renal function, and the dose of captopril given. A severe first dose effect cannot be consistently predicted in individual patients who have received other antihypertensive drugs for severe hypertension. Such patients should have close medical supervision for at least three hours after the first dose of captopril.

PubMed Disclaimer

References

    1. Am Heart J. 1970 Sep;80(3):329-42 - PubMed
    1. Eur J Clin Invest. 1971 Nov;2(1):32-8 - PubMed
    1. Phys Med Biol. 1978 May;23(3):405-15 - PubMed
    1. Prog Cardiovasc Dis. 1978 Nov-Dec;21(3):195-206 - PubMed
    1. Clin Chim Acta. 1980 Feb 14;101(1):5-15 - PubMed

Publication types

LinkOut - more resources